NASDAQ : FBIO
Fortress Biotech, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 66.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 64.03M |
| Enterprise Value | -79.23M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 33.35M |
| Shares Outstanding | 33.35M |
| Shares Change (YoY) | +25.98% |
| Shares Change (QoQ) | -17.24% |
| Owned by Insiders (%) | 22.17% |
| Owned by Institutions (%) | 17.51% |
| Float | 21.06M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 0.59 |
| Forward PE | 2.48 |
| PS Ratio | 0.94 |
| Forward PS | 1.45 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | 0.51 |
| P/OCF Ratio | 0.51 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.96 |
| Quick Ratio | 3.76 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.42 |
| Interest Coverage | -3.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 115.99% |
| Return on Assets (ROA) | -7.76% |
| Return on Invested Capital (ROIC) | -45.52% |
| Return on Capital Employed (ROCE) | -11.61% |
| Weighted Average Cost of Capital (WACC) | 14.00% |
| Revenue Per Employee | $877,769 |
| Profits Per Employee | $1.33M |
| Employee Count | 78 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 2.39 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.83M |
| Effective Tax Rate | 3.31% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -23.81% |
| 50-Day Moving Average | 2.31 |
| 200-Day Moving Average | 2.79 |
| Relative Strength Index (RSI) | 38.64 |
| Average Volume (20 Days) | 234,792 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.52M |
| Short Previous Month | 4.90M |
| Short % of Shares Out | 13.56% |
| Short % of Float | 21.48% |
| Short Ratio (days to cover) | 16.44 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 68.47M |
| Gross Profit | 43.32M |
| Operating Income | -29.58M |
| Pretax Income | 146.03M |
| Net Income | 103.37M |
| EBITDA | -24.98M |
| EBIT | -29.58M |
| Earnings Per Share (EPS) | $3.25 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 196.58M |
| Total Debt | 53.32M |
| Net Cash | 143.26M |
| Net Cash Per Share | $4.30 |
| Equity (Book Value) | 206.09M |
| Book Value Per Share | 4.93 |
| Working Capital | 183.49M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 125.92M |
| Capital Expenditures | -79,000 |
| Depreciation & Amortization | 4.60M |
| Net Borrowing | -75,000 |
| Free Cash Flow | 125.84M |
| FCF Per Share | $3.77 |
Margins
| Measure | Value |
|---|
| Gross Margin | 63.28% |
| Operating Margin | -43.20% |
| Pretax Margin | 213.28% |
| Profit Margin | 163.32% |
| EBITDA Margin | -36.48% |
| EBIT Margin | -43.20% |
| FCF Margin | 183.80% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -25.98% |
| Shareholder Yield | -25.98% |
| Earnings Yield | 169.24% |
| FCF Yield | 196.52% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 119.26% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 10, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.68 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |